• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Product › Details

clinical research

	Next higher product group	pharma services

Record changed: 2019-10-12

Advertisement

More documents for clinical research

• [1] Vivoryon Therapeutics AG. (10/8/19). "Press Release: Vivoryon Therapeutics AG Launches Rights Offering to Fund its Phase 2b Clinical Development Program in Alzheimer’s Disease with Strong Commitments [Not for US, et al.]". Halle (Saale)....
• [2] N-Side S.A.. (10/1/19). "Press Release: AstraZeneca Selects N-Side Suite for Clinical Trials to Optimize and Monitor Clinical Trial Supply Chain". Louvain-la-Neuve....
• [3] Adaptimmune Ltd.. (9/30/19). "Press Release: Clear Benefit for Patients with Synovial Sarcoma Demonstrated in Updated Data from Ongoing Phase 1 Trial with ADP-A2M4 Presented at ESMO". Philadeliphia, PA & Oxfordshire....
• [4] Newron Pharmaceuticals S.p.A.. (9/20/19). "Press Release: Newron Pharmaceutical Commercialization Partner Meiji Seika together with Eisai Announce the Approval of Safinamide for Parkinson’s Disease in Japan". Milan....
• [5] H. Lundbeck A/S. (9/20/19). "Press Release: Lundbeck and Takeda Announce Ministry of Health, Labour and Welfare (MHLW) Approval of Trintellix in Japan"....
• [6] AC Immune S.A.. (9/20/19). "Press Release: AC Immune Receives First Milestone Payment from Lilly in Small Molecule Tau Morphomer Program". Lausanne....
• [7] Roche. (9/18/19). "Press Release: FDA Grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis". Basel....
• [8] AC Immune S.A.. (9/17/19). "Press Release: AC Immune Receives Milestone Payment in Connection with Initiation of a Phase 2 Trial of Tau PET Tracer PI-2620". Lausanne....
• [9] MorphoSys AG. (9/16/19). "Press Release: MorphoSys's Licensee Janssen Submits Biologics License Application to U.S. FDA of Tremfya (Guselkumab) for Treatment of Adults with Active Psoriatic Arthritis". Planegg....
• [10] Devicare S.L.. (9/5/19). "Press Release: The PREVENTLIT Study Shows that Lit-Control Reduces new Episodes of Renal Lithiasis in Patients". Cerdanyola del Vallès....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.